Arcutis Biotherapeutics, Inc. vs UnitedHealth Group Incorporated — Stock Comparison

ARQT
Arcutis Biotherapeutics, Inc.
$23.35
▲ 0.56%
vs
UNH
UnitedHealth Group Incorporated
$368.78
▼ 0.46%
Q·Score Winner
Arcutis Biotherapeutics, Inc.
ARQT7/10vs 6.3/10

Q·Score Breakdown

7
Bullish
Overall
6.3
Neutral
2.6
Quality
6.2
8.2
Health
5.3
8.3
Growth
5.1
9.1
Valuation
7.3
7.9
Sentiment
8.1
ARQT

Consensus analyst target of $34.75 is 49% above current price.

currently unprofitable (-4% margin).

UNH

82% of 28 covering analysts have a positive rating.

limited growth momentum.

Analyst Consensus

BUY
Target $34.75 (+48.8%)
8 analysts
BUY
Target $387.27 (+5.0%)
26 analysts

Fundamentals

ARQT
UNH
Trailing P/E
27.9×
19.4×
Forward P/E
17.8×
-4.3%
Profit Margin
2.7%
90.2%
Gross Margin
18.8%
-9.3%
ROE
12.2%
81.5%
Revenue Growth
2.0%
Earnings Growth
0.7%
1.77
Beta
0.41
Price / Book
$2.9B
Market Cap
$334.9B
$12 – $32
52-Week Range
$235 – $410

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →